IDH2 and central nervous system cancer: This article provides an overview of IDH mutant gliomas, standard of care treatment, and novel therapeutic strategies, including IDH inhibitors, agents targeting DNA repair mechanisms and epigenetic vulnerabilities, and immunotherapy.